Evidence map›Paper›PMID 39586710›Full record

ArticleAnnals of family medicine

Improving Early Detection of Cognitive Impairment in Older Adults in Primary Care Clinics: Recommendations From an Interdisciplinary Geriatrics Summit.

Robin C Hilsabeck, William Perry, Laura Lacritz, Peter A Arnett, Raj C Shah, Soo Borson, James E Galvin, Kimberly Roaten, Morgan Daven, Ula Hwang and 8 more

Abstract read
In one paragraph

Article in Annals of family medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Robin C HilsabeckNational Academy of Neuropsychology, Denver, Colorado (Hilsabeck, Perry, Lacritz, Arnett) Hilsabeck@uthscsa.edu.
William PerryNational Academy of Neuropsychology, Denver, Colorado (Hilsabeck, Perry, Lacritz, Arnett).
Laura LacritzNational Academy of Neuropsychology, Denver, Colorado (Hilsabeck, Perry, Lacritz, Arnett).
Peter A ArnettNational Academy of Neuropsychology, Denver, Colorado (Hilsabeck, Perry, Lacritz, Arnett).
Raj C ShahRush University, Chicago, Illinois (Shah).
Soo BorsonUniversity of Southern California Keck School of Medicine, Los Angeles, California (Borson).
James E GalvinUniversity of Miami School of Medicine, Miami, Florida (Galvin).
Kimberly RoatenThe University of Texas Southwestern Medical Center, Dallas, Texas (Lacritz, Roaten).
Morgan DavenAlzheimer's Association, Chicago, Illinois (Daven).
Ula HwangNew York University Grossman School of Medicine, New York, New York (Hwang).
Laurie IveyUniversity of Colorado School of Medicine, Aurora, Colorado (Ivey).
Pallavi JoshiBanner Alzheimer's Institute, Phoenix, Arizona (Joshi).
Abby Luck ParishVanderbilt University, Nashville, Tennessee (Parish).
Julie WoodAmerican Academy of Family Physicians, Leawood, Kansas (Wood).
Jonathan WoodhouseComprehensive Neuropsychological Services, Cheshire, Connecticut (Woodhouse).
Jean TsaiIcahn School of Medicine at Mount Sinai, New York, New York (Tsai).
Michelle SorweidUniversity of Utah School of Medicine, Salt Lake City, Utah (Sorweid).
Usha SubramanianLong Beach Veterans Administration Healthcare System, Long Beach, California (Subramanian).

Funding

Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI ALIREZA ATRI · 2021 to 2026
$24.9M
NIA NIH HHS P30 AG072980
6 · The paper itself

Abstract

As the population ages, the prevalence of cognitive impairment due to neurodegenerative diseases such as Alzheimer disease (AD) is expected to double in the United States to nearly 14 million over the next 40 years. AD and related dementias (ADRD) are a leading cause of morbidity and mortality and among the costliest to society. Although emerging biomedical interventions for ADRD focus on early stages and are currently limited to AD, care management can benefit patients with ADRD across the disease course. Moreover, some causes of cognitive impairment are modifiable, and optimal overall management may slow or prevent additional decline. Nevertheless, a sizable proportion of cases of cognitive impairment among older adults remain undiagnosed. Primary care practitioners are often the first health care professionals to encounter cognitive concerns or to be able to observe changes in function resulting from cognitive impairment; hence, they have much to contribute to population health solutions for detecting cognitive impairment among older adults. In this report, we present key points and gaps in knowledge about methods for detecting cognitive impairment in primary care clinics. These were developed via an interdisciplinary Geriatrics Summit hosted by the National Academy of Neuropsychology in 2022, attended by representatives of national organizations engaged in work to improve care of older adults. We propose a novel workflow to facilitate detecting cognitive impairment during routine primary care, focusing on opportunities provided by the annual wellness visit, a preventive visit available to Medicare beneficiaries, along with additional recommendations and opportunities for clinical practice and research.

Indexed as

Cognitive DysfunctionEarly DiagnosisPrimary Health CareAgedAged, 80 and overAlzheimer DiseaseGeriatricsHumansUnited StatesAlzheimer’s diseasecognitive impairmentcognitive screeningdementiaearly detectionelderlyfamily physiciansgeriatricsneurodegenerative diseaseolder adultsprimary care

Identifiers

PMID39586710
PMCPMC11588378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.